Prognostic significance of six-minute walk test in non-group 1 pulmonary hypertension

Heart and Lung: Journal of Acute and Critical Care

Volumn 43, Issue 1, 2014, Pages 72-76

  Golpe, Rafael ^a   Castro Añón, Olalla ^a   Pérez de Llano, Luis A ^a   González Juanatey, Carlos ^a   Muñiz Fernández, Camino ^a   Testa Fernández, Ana ^a   Pérez Fernández, Ruth ^a  

^a HOSPITAL UNIVERSITARIO LUCUS AUGUSTI   (Spain)

Author keywords

Echocardiography; Exercise test; Hypertension; Mortality; Prognosis; Pulmonary

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR PARAMETERS; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GENERAL CONDITION DETERIORATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; RISK ASSESSMENT; SIX MINUTE WALK TEST; VERY ELDERLY; WALKING;

EID: 84891151932     PISSN: 01479563     EISSN: 15273288     Source Type: Journal    
DOI: 10.1016/j.hrtlng.2013.08.007     Document Type: Article

References (19)

1. McLaughlin V.V., Archer S.L., Badesch D.B., et al. ACCF/AHA 2009 consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation 2009, 119:2250-2294.
2. Simonneau G., Robbins I.M., Beghetti M., et al. Updated clinical classification of pulmonary hypertension. JAm Coll Cardiol 2009, 54:S43-S54.
3. McLaughlin V.V., Presberg K.W., Doyle R.L., et al. Prognosis of pulmonary arterial hypertension. ACCP evidence-based clinical practice guidelines. Chest 2004, 126:78S-92S.
4. Miyamoto S., Nagaya N., Satoh T., et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med 2000, 161:487-492.
5. Deboeck G., Scoditti C., Huez S., et al. Exercise to predict outcome in idiopathic vs associated pulmonary arterial hypertension. Eur Respir J 2012, 40:1410-1419.
6. Charlson M., Szatrowski T.P., Peterson J., Gold J. Validation of a combined comorbidity index. JClin Epidemiol 1994, 47:1245-1251.
7. McQuillan B.M., Picard M.H., Leavitt M., et al. Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects. Circulation 2001, 104:2797-2802.
8. Berger M., Haimowitz A., Van Tosh A., et al. Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. JAm Coll Cardiol 1985, 6:359-365.
9. Kircher B.J., Himelman R.B., Schiller N.B. Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. Am J Cardiol 1990, 66:493-496.
10. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002, 166:111-117.
11. Groepenhof H., Vonk-Noordegraaf A., Boonstra A., Spreeuwenberg M.D., Postmus P.E., Bogaard H.J. Exercise testing to estimate survival in pulmonary hypertension. Med Sci Sports Exerc 2008, 40:1725-1732.
12. Paciocco G., Martinez F.J., Bossone E., Pielsticker E., Gillespie B., Rubenfire M. Oxygen desaturation on the six-minute walk test and mortality in untreated primary pulmonary hypertension. Eur Respir J 2001, 17:647-652.
13. Rostagno C., Olivo G., Comeglio M., et al. Prognostic value of 6-minute walk corridor test in patients with mild to moderate heart failure: comparison with other methods of functional evaluation. Eur J Heart Fail 2003, 5:247-252.
14. Lama V.N., Flaherty K.R., Toews G.B., et al. Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2003, 168:1084-1090.
15. Pinto-Plata V.M., Cote C., Cabral H., Taylor J., Celli B.R. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J 2004, 23:28-33.
16. Blanco I., Gimeno E., Munoz P.A., et al. Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Am J Respir Crit Care Med 2010, 181:270-278.
17. Han M.K., Bach D.S., Hagan P., et al. Sildenafil preserves exercise capacity in IPF patients with right ventricular dysfunction. Chest 2013, 143:1699-1708.
18. Amin A., Mahmoudi E., Navid H., Chitsazan M. Is chronic sildenafil therapy safe and clinically beneficial in patients with systolic heart failureα. Congest Heart Fail 2013, 19:99-103.
19. Casanova C., Cote C., Marin J.M., et al. Distance and oxygen desaturation during the 6-min walk test as predictors of long term mortality in patients with COPD. Chest 2008, 134:746-752.